Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Shafran

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1989
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinationsA W Chow, J Wong, K H Bartlett, et al.
JAMA|September 18, 1998
Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research GroupF Diaz-Mitoma, R G Sibbald, S D Shafran, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1992
A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infectionsG E Garber, P Auger, R M Chan, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacinL E Nicolle, J DuBois, A Y Martel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complexF M Gordin, P M Sullam, S D Shafran, et al.
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
AIDS (London, England)|April 15, 1999
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, P Phillips, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpesS L Sacks, S D Shafran, F Diaz-Mitoma, et al.
International Journal of STD & AIDS|August 24, 2013
Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trialI S Gorfinkel, F Aoki, S McNeil, et al.
The Journal of Infectious Diseases|July 1, 1997
Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trialS D Shafran, S L Sacks, F Y Aoki, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|August 1, 1989
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinationsA W Chow, J Wong, K H Bartlett, et al.
JAMA|September 18, 1998
Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research GroupF Diaz-Mitoma, R G Sibbald, S D Shafran, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1992
A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infectionsG E Garber, P Auger, R M Chan, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacinL E Nicolle, J DuBois, A Y Martel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complexF M Gordin, P M Sullam, S D Shafran, et al.
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
AIDS (London, England)|April 15, 1999
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, P Phillips, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpesS L Sacks, S D Shafran, F Diaz-Mitoma, et al.
International Journal of STD & AIDS|August 24, 2013
Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trialI S Gorfinkel, F Aoki, S McNeil, et al.
The Journal of Infectious Diseases|July 1, 1997
Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trialS D Shafran, S L Sacks, F Y Aoki, et al.
Pageof 6